Kinnevik AB’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,683,668
Closed -$87.1M 3
2022
Q4
$87.1M Hold
3,683,668
49.14% 1
2022
Q3
$93.4M Hold
3,683,668
78.26% 1
2022
Q2
$122M Hold
3,683,668
69.48% 1
2022
Q1
$266M Sell
3,683,668
-1,307,456
-26% -$94.2M 55.42% 1
2021
Q4
$458M Buy
+4,991,124
New +$597M 58.86% 1

Other funds holding TDOC

Kinnevik AB's TDOC Position: Q1 2023 in Review

Kinnevik AB sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 3,683,668 shares — an estimated $87.1M sold.

Kinnevik AB first reported a position in TDOC in Q4 2021 and held it in 5 quarters. The position peaked at $458M in Q4 2021. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Kinnevik AB reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Kinnevik AB sold 3,683,668 Teladoc Health shares in Q1 2023, an estimated $87.1M.
  • Kinnevik AB first reported a position in Teladoc Health in Q4 2021 and held it in 5 quarters.
  • Kinnevik AB's Teladoc Health position peaked at $458M in Q4 2021.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Kinnevik AB's 13F filing for Q1 2023, filed 14 Apr 2023.